Apollomics, Inc. Announces Initiation of SPARTA Phase 2 Clinical Trial for c-MET Inhibitor APL-101

    NEXT STORY
    Global Hospital Cleaning Chemicals Market Forecast to Grow by $ 2.96 Billion during 2020-2024. Progressing at a CAGR of 9%
    PREV STORY
    Apellis Announces Plans to Submit NDA for Pegcetacoplan in Paroxysmal Nocturnal Hemoglobinuria (PNH)
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    MediciNova Announces MN-001 Research Collaboration with The Jikei University School of Medicine in Tokyo, Japan

    author_avatar
    NASDAQ Market News

    Hypochlorite Bleaches Market revenue to cross USD 340 Million-mark by 2025: Global Market Insights, Inc.

    author_avatar
    NASDAQ Market News

    New data demonstrate Sandoz proposed biosimilar adalimumab has equivalent efficacy to reference medicine

    Sandoz proposed biosimilar adalimumab (GP2017) shown to have equivalent efficacy and a similar safety ...

    author_avatar
    NASDAQ Market News